Nic Bioscience Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 1.00 M
as on 24-10-2024
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.50 Cr
as on 24-10-2024
- Revenue 31397.93%
(FY 2023)
- Profit -2520.55%
(FY 2023)
- Ebitda 454.95%
(FY 2023)
- Net Worth -1245.92%
(FY 2023)
- Total Assets 11.61%
(FY 2023)
About Nic Bioscience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.50 Cr.
Anantkumar Ramolia, Jayantilal Ramolia, and Kaushik Ramoliya serve as directors at the Company.
- CIN/LLPIN
U24304GJ2017PTC095801
- Company No.
095801
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Feb 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Bharuch, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Nic Bioscience?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayantilal Ramolia  | Director | 15-Feb-2017 | Current |
| Anantkumar Ramolia | Director | 15-Feb-2017 | Current |
| Kaushik Ramoliya | Director | 15-Feb-2017 | Current |
Financial Performance of Nic Bioscience.
Nic Bioscience Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31397.93% increase. The company also saw a substantial fall in profitability, with a 2520.55% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1245.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nic Bioscience?
In 2023, Nic Bioscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 Sep 2020 | ₹3.50 Cr | Open |
How Many Employees Work at Nic Bioscience?
Unlock and access historical data on people associated with Nic Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nic Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nic Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
